Central line-associated bloodstream infections were reduced by 38 percent across 18 ICUs in seven Abu Dhabi hospitals, thanks to a bundled intervention developed by researchers from the Johns Hopkins ...
An investigation of central-line associated bloodstream infection data by the Colorado Department of Public Health and Environment in several Colorado hospitals found that CLABSI data reporting relied ...
Overall, the latest report — the first to show hospital performance post-pandemic, according to Leapfrog — found 30% of hospitals attained an A grade, 24% scored a B, 39% earned a C, 7% received a D ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DECATUR, Ala. (WHNT) – The Decatur Morgan ...
Less than a decade ago, central-line associated bloodstream infections (CLABSIs) were considered the most pervasive of all hospital-associated illnesses (HAIs). Across the United States, 500,000 ...
ITHACA, N.Y. — Cayuga Medical Center announced on Thursday that it has reached more than 1,200 consecutive days without a Central Line Associated Bloodstream Infection, or CLABSI. CLABSI is a serious, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Acute-care hospitals saw significant improvement in many ...
MISSISSAUGA, ON, March 27, 2023 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced the second ...
The Joint Commission has released a new report (pdf) detailing the most up-to-date evidence and recommendations for preventing central line-associated bloodstream infections. “Preventing Central ...
Though researchers found the same increasing trend for the incidence of UVC-associated CLABSI when the dwell time increased, as in previous studies, this study showed no significant difference in ...
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs) ...
The health system has focused on catheter-associated urinary tract infection, central line-associated bloodstream infection, Clostridium difficile, methicillin-resistant Staphylococcus aureus, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results